AbbVie Inc (ABBV)
163.79
+2.98
(+1.85%)
USD |
NYSE |
May 03, 16:00
163.50
-0.29
(-0.18%)
After-Hours: 20:00
AbbVie Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.688B |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 2.934B |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 2.882B |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 2.276B |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 1.452B |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 1.546B |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 1.474B |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.407B |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 1.597B |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 1.401B |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 933.00M |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 556.00M |
| September 30, 2012 | 423.91M |
| June 30, 2012 | 337.12M |
| March 31, 2012 | 476.13M |
| December 31, 2011 | 417.00M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.452B
Minimum
Dec 2019
3.688B
Maximum
Dec 2023
2.646B
Average
2.882B
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
| Amgen Inc | 1.628B |
| Johnson & Johnson | 8.174B |
| Eli Lilly and Co | 2.474B |
| Merck & Co Inc | 3.922B |
| Pfizer Inc | 6.71B |